Our showcase of measure and measurePRO at the MEDICA tradefair was featured in several publications: Digital Health Age Oxford Uni Spin-Out Showcases Digital Bowel Cancer Test at MEDICA Med-Tech Innovation News The ABHI UK Pavilion at Medica: Why Healthtech Will Be a Key Focus UK Export News World First Digital Testing Device For Early Bowel […]
Our partner company in Tianjin, China is proud to announce that it has gained ISO 9001 and ISO 13485 certification.
Oxford MEStar will be attending the MEDICA trade fair in Düsseldorf, Germany, November 18th-21st 2019. We will be showcasing our product as part of the ABHI UK pavillion in Hall 16 (stand 16K03-3).
Oxford MEStar will be attending ARAB Health, held in Dubai on Januaray 27th to 31st, to promote measure bowel health. We will be showcasing our product as part of the ABHI UK pavillion (Hall 7).
Deborah Gilbert (CEO, Bowel & Cancer Research) went live on Sky News Sunrise to discuss the importance of early screening in detecting invisible signs of bowel disease including cancer. Early detection can save lives. 9 in 10 people will survive for 5 years or more when bowel cancer symptoms are caught at stage one. Measure […]
The EU grant will “support development and streamlined integration of 3D printing technologies to enable advanced medical treatment and its widespread application” Oxford, UK, 20 September 2018 – Oxford MEStar today announced that it has been awarded funding to take part in a 36-month, € 6.84 Million project under the European Union Interreg 2 Seas […]
Japanese government and industry are putting huge resources into cell therapy and regenerative medicine. Oxford MEStar was honoured to be selected to take part in a UK trade mission to Japan, which took place in February. Here are some video highlights:
Oxford MEStar announce the launch of measure bowel health test measure Bowel Health is an affordable DIY Bowel Health Test that combines ease of use with cutting edge digital technology. measure is fast, hygienic and discreet and it works by detecting low-level bleeding invisible to the human eye that may be an early sign of […]
Grant to support development of novel manufacturing system to assist in production of innovative cancer treatments Oxford, UK, 05 December 2017 – Oxford MEStar, in collaboration with the Cell and Gene Therapy (CGT) Catapult and AK (Suzhou) Biomedical, today announced it has been awarded a share of a £1 million grant from the Innovate UK-Jiangsu […]
